The Minnesota House of Representatives passed an omnibus health finance bill on April 26 with a 69-58 vote. The bill, SF-2995, contains provisions to create a Psychedelic Medicine Task Force in order to proactively prepare for legalization. The task force would be “established to advise the legislature on the legal, medical, and policy issues associated with the legalization of psychedelic medicine in the state.”
SF-2995 was initially introduced in the Senate in March, and was passed with a third reading on April 19, and received amendments in the House over the past few weeks.
Task force duties include surveying “existing studies in the scientific literature on the therapeutic efficacy of psychedelic medicine in the treatment of mental health conditions, including depression, anxiety, post-traumatic stress disorder, and bipolar disorder, and any other mental health conditions and medical conditions for which a psychedelic medicine may provide an effective treatment option.”
It would also be required to apply necessary changes that apply to “legalization of psychedelic medicine,” “state and local regulation of psychedelic medicine,” and educating the public regarding legislative recommendations.
Read More at
Minnesota Omnibus Health Bill Includes Provisions for Psychedelic Task Force
